{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:56:41Z","timestamp":1787497001812,"version":"build-2736575974"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.coph.2026.102631","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T07:03:22Z","timestamp":1776841402000},"page":"102631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The neuro-metabolic epidemic and the CB1R paradox"],"prefix":"10.1016","volume":"89","author":[{"given":"Francesca","family":"Vaccaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginevra","family":"Malta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfredi","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4786-8435","authenticated-orcid":false,"given":"Fulvio","family":"Plescia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Lavanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2026.102631_bib1","doi-asserted-by":"crossref","first-page":"11955","DOI":"10.3390\/ijms252211955","article-title":"Alzheimer's disease as type 3 diabetes: understanding the link and implications","volume":"25","author":"Kciuk","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coph.2026.102631_bib2","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.3390\/ijms23052687","article-title":"Alzheimer's disease as type 3 diabetes: common pathophysiological mechanisms between Alzheimer's disease and type 2 diabetes","volume":"23","author":"Michailidis","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coph.2026.102631_bib3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40035-024-00435-8","article-title":"Neurodegenerative disorders, metabolic icebergs, and mitohormesis","volume":"13","author":"Phillips","year":"2024","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.coph.2026.102631_bib4","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41420-023-01732-3","article-title":"Decoding metabolic signatures in Alzheimer's disease: a mitochondrial perspective","volume":"9","author":"Bano","year":"2023","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.coph.2026.102631_bib5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/joim.70036","article-title":"Bioenergetics and lipid metabolism in Alzheimer's disease: from cell biology to systemic health","volume":"299","author":"Maioli","year":"2026","journal-title":"J Intern Med"},{"key":"10.1016\/j.coph.2026.102631_bib6","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3390\/jcm10071532","article-title":"Brain glucose metabolism in health, obesity, and cognitive decline\u2014does insulin have Anything to Do with it? A narrative review","volume":"10","author":"Rebelos","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.coph.2026.102631_bib7","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.3390\/ijms26094209","article-title":"Peripheral inflammation and insulin resistance: their impact on blood\u2013brain barrier integrity and glia activation in Alzheimer's disease","volume":"26","author":"Ponce-Lopez","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coph.2026.102631_bib8","doi-asserted-by":"crossref","first-page":"11301","DOI":"10.3390\/ijms241411301","article-title":"Potential role of glucagon-like Peptide-1 receptor agonists in the treatment of cognitive decline and dementia in diabetes mellitus","volume":"24","author":"Pelle","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coph.2026.102631_bib9","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.3390\/ph18101527","article-title":"Adipokines at the metabolic\u2013brain interface: therapeutic modulation by antidiabetic agents and natural compounds in Alzheimer's disease","volume":"18","author":"Ormazabal","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.coph.2026.102631_bib10","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3390\/nu17071203","article-title":"Mechanisms linking obesity, insulin resistance, and Alzheimer's disease: effects of polyphenols and Omega-3 polyunsaturated fatty acids","volume":"17","author":"Yavari","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.coph.2026.102631_bib11","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3233\/JAD-230555","article-title":"de la Monte SM: Malignant Brain Aging: the Formidable Link Between Dysregulated Signaling Through Mechanistic Target of Rapamycin Pathways and Alzheimer's Disease (Type 3 Diabetes)","volume":"95","year":"2023","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.coph.2026.102631_sref12","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.3390\/ijms26062420","article-title":"A combined GLP-1\/PPARa\/CB1-Based therapy to restore the central and peripheral metabolic dysregulation induced by a high-fructose high-fat diet","volume":"26","author":"de Ceglia","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coph.2026.102631_bib13","doi-asserted-by":"crossref","DOI":"10.34133\/research.0326","article-title":"Resistin regulates inflammation and insulin resistance in humans via the endocannabinoid system","volume":"6","author":"Yang","year":"2024","journal-title":"Research"},{"key":"10.1016\/j.coph.2026.102631_bib14","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3390\/biomedicines11020306","article-title":"Role of the endocannabinoid system in metabolic control processes and in the pathogenesis of metabolic syndrome: an update","volume":"11","author":"D\u00f6rnyei","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.coph.2026.102631_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.7868\/S3034611825030013","article-title":"Brain insulin: delivery routes, mechanisms of action, and application of intranasal insulin for the treatment of diabetes mellitus and metabolic syndrome","volume":"56","author":"Shpakov","year":"2025","journal-title":"\u0423\u0441\u043f\u0435\u0445\u0438 \u0444\u0438\u0437\u0438\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0445 \u043d\u0430\u0443\u043a\/Prog Physiol Sci"},{"key":"10.1016\/j.coph.2026.102631_bib16","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1002\/ptr.8078","article-title":"Coffee peel polyphenols ameliorate nonalcoholic fatty liver disease by modulating cannabinoid receptor type-1-ceramide axis","volume":"39","author":"Fan","year":"2025","journal-title":"Phytother Res"},{"key":"10.1016\/j.coph.2026.102631_bib17","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2015990118","article-title":"Endogenous cannabinoids are required for MC4R-mediated control of energy homeostasis","volume":"118","author":"Yong","year":"2021","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.coph.2026.102631_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00429-024-02876-3","article-title":"Growth hormone secretagogue receptor and cannabinoid receptor type 1 intersection in the mouse brain","volume":"230","author":"Saenz","year":"2024","journal-title":"Brain Struct Funct"},{"key":"10.1016\/j.coph.2026.102631_bib19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3390\/cells13050461","article-title":"Overactivation of the endocannabinoid system in adolescence disrupts adult adipose organ function in mice","volume":"13","author":"Jung","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.coph.2026.102631_bib20","doi-asserted-by":"crossref","first-page":"12635","DOI":"10.3390\/ijms232012635","article-title":"Cannabinoid CB1 receptor deletion from catecholaminergic neurons protects from diet-induced obesity","volume":"23","author":"Srivastava","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coph.2026.102631_bib21","doi-asserted-by":"crossref","first-page":"13797","DOI":"10.3390\/ijms241813797","article-title":"The effect of orally administered \u03949-Tetrahydrocannabinol (THC) and cannabidiol (CBD) on obesity parameters in mice","volume":"24","author":"Eitan","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coph.2026.102631_bib22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3390\/toxins11050275","article-title":"Cannabis: from a plant that modulates feeding behaviors toward developing selective inhibitors of the peripheral endocannabinoid system for the treatment of obesity and metabolic syndrome","volume":"11","author":"Hirsch","year":"2019","journal-title":"Toxins"},{"key":"10.1016\/j.coph.2026.102631_bib23","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.60771","article-title":"CB1R regulates soluble leptin receptor levels via CHOP, contributing to hepatic leptin resistance","volume":"9","author":"Drori","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.coph.2026.102631_bib24","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/s41366-021-00820-7","article-title":"GHS-R suppression in adipose tissues protects against obesity and insulin resistance by regulating adipose angiogenesis and fibrosis","volume":"45","author":"Lee","year":"2021","journal-title":"Int J Obes"},{"key":"10.1016\/j.coph.2026.102631_bib25","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41366-021-00996-y","article-title":"Obesity risk is associated with altered cerebral glucose metabolism and decreased \u03bc-opioid and CB1 receptor availability","volume":"46","author":"Kantonen","year":"2022","journal-title":"Int J Obes"},{"key":"10.1016\/j.coph.2026.102631_bib26","doi-asserted-by":"crossref","DOI":"10.2337\/db25-1716-P","article-title":"1716-P: Nimacimab, a peripherally restricted CB1 inhibitor, promotes metabolic homeostasis in a diet-induced obesity (DIO) mouse model as demonstrated by weight loss, restored hormonal regulation, and reduced inflammatory biomarkers","volume":"74","author":"Ruiz-Pino","year":"2025","journal-title":"Diabetes"},{"key":"10.1016\/j.coph.2026.102631_bib27","doi-asserted-by":"crossref","first-page":"15645","DOI":"10.1038\/s41598-017-15154-6","article-title":"Blockade of CB1 cannabinoid receptor alters gut microbiota and attenuates inflammation and diet-induced obesity","volume":"7","author":"Mehrpouya-Bahrami","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.coph.2026.102631_bib28","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/acel.12438","article-title":"CB 1 receptor blockade counters age-induced insulin resistance and metabolic dysfunction","volume":"15","author":"Lipina","year":"2016","journal-title":"Aging Cell"},{"key":"10.1016\/j.coph.2026.102631_bib29","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.pharep.2018.06.004","article-title":"The role of (E)-6-chloro-3-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-2-styrylquinazolin-4(3H)-one in the modulation of cannabinoidergic system. A pilot study","volume":"70","author":"Plescia","year":"2018","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.coph.2026.102631_sref30","doi-asserted-by":"crossref","first-page":"177973","DOI":"10.1016\/j.ejphar.2025.177973","article-title":"Pharmacological characterization of a new synthesis compound with antagonistic action on CB1 receptors: evidence from the animal experimental model","volume":"1003","author":"Plescia","year":"2025","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.coph.2026.102631_bib31","first-page":"173","article-title":"Rimonabant: the evidence for its use in the treatment of obesity and the metabolic syndrome","volume":"2","author":"Waterlow","year":"2008","journal-title":"Core Evid"},{"key":"10.1016\/j.coph.2026.102631_bib32","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/oby.24019","article-title":"Seventeen years since rimonabant's downfall: reassessing its suicidality risk profile","volume":"32","author":"Cohen","year":"2024","journal-title":"Obesity"},{"key":"10.1016\/j.coph.2026.102631_sref33","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/jnc.15922","article-title":"Type-1 cannabinoid receptors and their ever-expanding roles in brain energy processes","volume":"168","author":"Fern\u00e1ndez-Moncada","year":"2024","journal-title":"J Neurochem"},{"key":"10.1016\/j.coph.2026.102631_bib34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cmet.2016.12.020","article-title":"(S)Pot on mitochondria: cannabinoids disrupt cellular respiration to limit neuronal activity","volume":"25","author":"Harkany","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.coph.2026.102631_bib35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1515\/revneuro-2025-0086","article-title":"Implications of the mitochondrial CB1 receptor in the brain: from mitochondrial dysfunction to neuroprotection","volume":"37","author":"Mart\u00ednez-Torres","year":"2026","journal-title":"Rev Neurosci"},{"key":"10.1016\/j.coph.2026.102631_bib36","doi-asserted-by":"crossref","first-page":"6842","DOI":"10.1038\/s41467-024-51008-2","article-title":"A lactate-dependent shift of glycolysis mediates synaptic and cognitive processes in male mice","volume":"15","author":"Fern\u00e1ndez-Moncada","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2026.102631_bib37","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41586-020-2470-y","article-title":"Glucose metabolism links astroglial mitochondria to cannabinoid effects","volume":"583","author":"Jimenez-Blasco","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.coph.2026.102631_bib38","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.3390\/molecules26175413","article-title":"CB1 cannabinoid receptor signaling and biased signaling","volume":"26","author":"Leo","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.coph.2026.102631_bib39","doi-asserted-by":"crossref","first-page":"10743","DOI":"10.3390\/ijms262110743","article-title":"GLP-1 and the degenerating brain: exploring mechanistic insights and therapeutic potential","volume":"26","author":"Moaket","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coph.2026.102631_bib40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature14260","article-title":"Hypothalamic POMC neurons promote cannabinoid-induced feeding","volume":"519","author":"Koch","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.coph.2026.102631_bib41","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3390\/ijms23020739","article-title":"GLP-1a: going beyond traditional use","volume":"23","author":"Laurindo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coph.2026.102631_bib42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41392-020-00298-1","article-title":"The p(l)ot thickens: cannabinoid receptors on astroglial mitochondria coordinate animal behaviors by regulating lactate availability for neurons","volume":"5","author":"Keimpema","year":"2020","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.coph.2026.102631_bib43","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nn.3053","article-title":"Mitochondrial CB1 receptors regulate neuronal energy metabolism","volume":"15","author":"B\u00e9nard","year":"2012","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.coph.2026.102631_bib44","doi-asserted-by":"crossref","DOI":"10.1530\/JME-23-0112","article-title":"Cellular mechanisms of incretin hormone secretion","volume":"72","author":"Santos-Hern\u00e1ndez","year":"2024","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.coph.2026.102631_bib45","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.coph.2026.102631_bib46","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2337\/dbi21-0002","article-title":"GIPR function in the central nervous system: implications and novel perspectives for GIP-based therapies in treating metabolic disorders","volume":"70","author":"Samms","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.coph.2026.102631_bib47","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/antiox10010078","article-title":"Role of Exendin-4 in brain insulin resistance, mitochondrial function, and neurite outgrowth in neurons under palmitic acid-induced oxidative stress","volume":"10","author":"Jo","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.coph.2026.102631_bib48","doi-asserted-by":"crossref","first-page":"525","DOI":"10.4093\/dmj.2025.0242","article-title":"Exploring the side effects of GLP-1 receptor agonist: to ensure its optimal positioning","volume":"49","author":"Kim","year":"2025","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.coph.2026.102631_bib49","doi-asserted-by":"crossref","first-page":"S317","DOI":"10.3233\/JAD-240069","article-title":"Conquering insulin network dysfunctions in Alzheimer's disease: where Are we today?","volume":"101","author":"de la Monte","year":"2024","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.coph.2026.102631_bib50","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3233\/JAD-180584","article-title":"The novel DA\u2013CH3 dual incretin restores endoplasmic reticulum stress and autophagy impairments to attenuate alzheimer-like pathology and cognitive decrements in the APP SWE\/PS1 \u0394E9 mouse Model","volume":"66","author":"Panagaki","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.coph.2026.102631_bib51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molmet.2018.09.009","article-title":"LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept","volume":"18","author":"Coskun","year":"2018","journal-title":"Mol Metabol"},{"key":"10.1016\/j.coph.2026.102631_bib52","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2174\/187152411798047771","article-title":"Gastric inhibitory polypeptide and its receptor are expressed in the central nervous system and support neuronal survival","volume":"11","author":"Paratore","year":"2011","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"10.1016\/j.coph.2026.102631_bib53","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5483\/BMBRep.2024-0067","article-title":"Glucose-dependent insulinotropic polypeptide (GIP) alleviates ferroptosis in aging-induced brain damage through the Epac\/Rap1 signaling pathway","volume":"57","author":"Ko","year":"2024","journal-title":"BMB Rep"},{"key":"10.1016\/j.coph.2026.102631_bib54","doi-asserted-by":"crossref","DOI":"10.1177\/17562864251332035","article-title":"The therapeutic effects and mechanisms of glucagon-like peptide-1 receptor agonists in neurocognitive disorders","volume":"18","author":"Si","year":"2025","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.coph.2026.102631_bib55","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1172\/JCI68295","article-title":"Exenatide and the treatment of patients with Parkinson's disease","volume":"123","author":"Aviles-Olmos","year":"2013","journal-title":"J Clin Investig"},{"key":"10.1016\/j.coph.2026.102631_bib56","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/S0140-6736(17)31585-4","article-title":"Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Athauda","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2026.102631_bib57","doi-asserted-by":"crossref","DOI":"10.2139\/ssrn.4212371","article-title":"A phase II, randomized, double-blinded, placebo-controlled trial of liraglutide in Parkinson's disease","author":"Hogg","year":"2022","journal-title":"SSRN Electron J"},{"key":"10.1016\/j.coph.2026.102631_sref58","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1056\/NEJMoa2312323","article-title":"Trial of lixisenatide in early Parkinson's disease","volume":"390","author":"Meissner","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coph.2026.102631_bib59","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13063-019-3259-x","article-title":"Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study)","volume":"20","author":"Femminella","year":"2019","journal-title":"Trials"},{"key":"10.1016\/j.coph.2026.102631_sref60","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1177\/13872877251351329","article-title":"Associations of semaglutide with Alzheimer's disease-related dementias in patients with type 2 diabetes: a real-world target trial emulation study","volume":"106","author":"Wang","year":"2025","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.coph.2026.102631_sref61","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41591-025-04106-7","article-title":"Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trial","volume":"32","author":"Edison","year":"2026","journal-title":"Nat Med"},{"key":"10.1016\/j.coph.2026.102631_sref62","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13195-024-01666-7","article-title":"Evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease","volume":"17","author":"Cummings","year":"2025","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.coph.2026.102631_bib63","doi-asserted-by":"crossref","first-page":"108824","DOI":"10.1016\/j.pharmthera.2025.108824","article-title":"GLP-1 receptor agonists, are we witnessing the emergence of a paradigm shift for neuro-cardio-metabolic disorders?","volume":"269","author":"Arredouani","year":"2025","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.coph.2026.102631_bib64","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/biom16010099","article-title":"Impaired brain incretin and gut hormone expression in human alcohol-related brain damage: opportunities for therapeutic targeting","volume":"16","author":"de la Monte","year":"2026","journal-title":"Biomolecules"},{"key":"10.1016\/j.coph.2026.102631_bib65","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3390\/pharmaceutics16060693","article-title":"Cyclic adenosine monophosphate in cardiac and sympathoadrenal GLP-1 receptor signaling: focus on anti-inflammatory effects","volume":"16","author":"Lymperopoulos","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.coph.2026.102631_bib66","doi-asserted-by":"crossref","first-page":"C1793","DOI":"10.1152\/ajpcell.00168.2025","article-title":"GLP-1 and ghrelin inversely regulate insulin secretion and action in pancreatic islets, vagal afferents, and hypothalamus for controlling glycemia and feeding","volume":"328","author":"Yada","year":"2025","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.coph.2026.102631_bib67","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2337\/db20-0162","article-title":"CB1 and GLP-1 receptors cross talk provides new therapies for obesity","volume":"70","author":"Zizzari","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.coph.2026.102631_bib68","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1002\/oby.23902","article-title":"Novel <scp>cannabinoid receptor 1<\/scp> inverse agonist <scp>CRB<\/scp> -913 enhances efficacy of tirzepatide, semaglutide, and liraglutidein the <scp>diet-induced obesity<\/scp> mouse model","volume":"31","author":"Morningstar","year":"2023","journal-title":"Obesity"},{"key":"10.1016\/j.coph.2026.102631_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.699661","article-title":"An autonomous cannabinoid system in islets of Langerhans","volume":"12","author":"Aseer","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.coph.2026.102631_bib70","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1152\/physiol.00029.2020","article-title":"Cannabinoid receptors in metabolic regulation and diabetes","volume":"36","author":"Rohbeck","year":"2021","journal-title":"Physiology"},{"key":"10.1016\/j.coph.2026.102631_sref71","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.gastha.2024.07.006","article-title":"Cannabinoids block fat-induced incretin release via CB1-dependent and CB1-independent pathways in intestinal epithelium","volume":"3","author":"Perez","year":"2024","journal-title":"Gastro Hep Advances"},{"key":"10.1016\/j.coph.2026.102631_bib72","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12944-021-01609-3","article-title":"(Wh)olistic (E)ndocannabinoidome-microbiome-axis modulation through (N)utrition (WHEN) to curb obesity and related disorders","volume":"21","author":"Sihag","year":"2022","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.coph.2026.102631_bib73","doi-asserted-by":"crossref","DOI":"10.14309\/ajg.0000000000003907","article-title":"The enterolimbic axis: gut-brain affective circuits at the crossroad of metabolism, emotion, and behavior","author":"Gasbarrini","year":"2026","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2026.102631_bib74","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s40618-023-02228-8","article-title":"Endocannabinoid-related molecules predict the metabolic efficacy of GLP-1 receptor agonism in humans with obesity","volume":"47","author":"Matias","year":"2023","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.coph.2026.102631_bib75","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.neuron.2017.02.002","article-title":"The CB1 receptor as the cornerstone of exostasis","volume":"93","author":"Piazza","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.coph.2026.102631_bib76","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.4103\/NRR.NRR-D-24-01422","article-title":"Mitochondrial dynamics dysfunction and neurodevelopmental disorders: from pathological mechanisms to clinical translation","volume":"21","author":"Yang","year":"2026","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.coph.2026.102631_bib77","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nature20127","article-title":"A cannabinoid link between mitochondria and memory","volume":"539","author":"Hebert-Chatelain","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.coph.2026.102631_sref78","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1038\/s41593-025-02032-y","article-title":"Potentiation of mitochondrial function by mitoDREADD-Gs reverses pharmacological and neurodegenerative cognitive impairment in mice","volume":"28","author":"Pagano Zottola","year":"2025","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.coph.2026.102631_bib79","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.3390\/cells11162582","article-title":"Expression of functional cannabinoid Type-1 (CB1) receptor in mitochondria of white adipocytes","volume":"11","author":"Pagano Zottola","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.coph.2026.102631_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.720734","article-title":"Cannabinoid receptor 1 inhibition in chronic kidney disease: a new therapeutic toolbox","volume":"12","author":"Dao","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.coph.2026.102631_bib81","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.2337\/db08-0161","article-title":"Peripheral, but Not central, CB1 antagonism provides food intake\u2013independent metabolic benefits in diet-induced Obese rats","volume":"57","author":"Nogueiras","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.coph.2026.102631_bib82","doi-asserted-by":"crossref","first-page":"7645","DOI":"10.1113\/JP286293","article-title":"Incretin hormones and obesity","volume":"603","author":"Alcaino","year":"2025","journal-title":"J Physiol"},{"key":"10.1016\/j.coph.2026.102631_bib83","doi-asserted-by":"crossref","first-page":"118144","DOI":"10.1016\/j.biopha.2025.118144","article-title":"Gestational THC exposure perturbates hippocampal mitochondrial respiration in the memory-impaired adolescent progeny: is there a role for mitochondrial CB1 receptor?","volume":"187","author":"Lavanco","year":"2025","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.coph.2026.102631_bib84","doi-asserted-by":"crossref","first-page":"10694","DOI":"10.1038\/s41467-024-54206-0","article-title":"Structural mechanism of CB1R binding to peripheral and biased inverse agonists","volume":"15","author":"Kumari","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2026.102631_bib85","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.13677","article-title":"The effects of glucagon-like Peptide-1 receptor agonists on mitochondrial function within skeletal muscle: a systematic review","volume":"16","author":"Old","year":"2025","journal-title":"J Cachexia Sarcopenia Muscle"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489226000275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489226000275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T16:26:51Z","timestamp":1784910411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489226000275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":85,"alternative-id":["S1471489226000275"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2026.102631","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The neuro-metabolic epidemic and the CB1R paradox","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2026.102631","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102631"}}